Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR201705002263637Not yet recruiting
Trial of lornoxicam in propofol injection site pain (PISP) (2 arms), sponsored by Post Graduate Medical Education Programme. Primary endpoint: Intensity of propofol injection pain. Planned start Aug 2017; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR201705002263637.